CureVac Plans Global Late-stage COVID-19 Vaccine Trial In Fourth Quarter

Germany's CureVac NV said on Tuesday it has started a midstage study testing its experimental coronavirus vaccine and plans to begin a decisive global trial with about 30,000 volunteers in the fourth quarter.

from Top Business News- News18.com https://ift.tt/36hX4sl